Flowchart of patient identification.

<p>DM, diabetes mellitus; DMARD, disease-modifying antirheumatic drug; JMDC, Japan Medical Data Center; RA, rheumatoid arthritis.</p>

Saved in:

Bibliographic Details
Main Author:	Eiichi Tanaka (1665016) (author)
Other Authors:	Eisuke Inoue (400274) (author), Ryoko Sakai (3120840) (author), Katsuhiko Iwasaki (2333305) (author), Ayako Shoji (78037) (author), Masayoshi Harigai (18940) (author)
Published:	2025
Subjects:	Biochemistry Medicine Pharmacology Ecology Immunology Developmental Biology Marine Biology Science Policy without diabetes mellitus month duration post charlson comorbidity index modifying antirheumatic drug first ra codes xlink "> data cci ), months 7 %/ 5 total medical costs evaluate medical costs ra without dm dm group compared baseline period constituted dm group patients xlink "> medical costs dm group index date drug costs antidiabetic drug excluding dm dm prescribed ra diagnosis treatment costs specific costs material costs secondary endpoints rheumatoid arthritis resource use primary endpoint periods belonged patients using median values claims database biological disease antidiabetic prescription 782 usd 59 years 5 %). 242 usd 163 usd 109 patients 066 usd
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items